Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2014 14:45 ET | Source: Qu Biologics

Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
February 20, 2014 20:49 ET | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
February 18, 2014 09:00 ET | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
January 22, 2014 10:10 ET | Source: Qu Biologics

Qu Biologics Granted Broad Australian Patent for Targeted Treatment of Multiple Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 22, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
December 11, 2013 11:05 ET | Source: Qu Biologics

Qu Biologics Appoints Rashieda Gluck as Vice President, Clinical Operations

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the...
December 06, 2013 05:30 ET | Source: Qu Biologics

Qu Biologics Granted Broad European Patent for Targeted Treatment of Multiple Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 6, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
December 04, 2013 09:45 ET | Source: Qu Biologics

Qu Biologics Appoints Dr. David Mullins as Chief Scientific Officer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the body's...
December 03, 2013 10:00 ET | Source: Qu Biologics

Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...
August 15, 2013 12:42 ET | Source: Qu Biologics

Qu Biologics Begins Research With McMaster University to Study Chronic Inflammation Associated With Macrophage Dysfunction

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
August 07, 2013 09:15 ET | Source: Noble

Noble Expands Into Global Biologics Market With Multisensory Device Training

ORLANDO, FL--(Marketwired - Aug 7, 2013) - Noble®, the leader in the design and manufacturing of training devices, is expanding its services to the global biologics market, offering...